Abstract
We thank A. Agusti for his interest in the European Respiratory Society (ERS) guideline on withdrawal of inhaled corticosteroids (ICS) in COPD [1]. He raises an important concern, that we might be recommending discontinuing a potentially effective treatment. This was carefully considered by the panel and there are important reasons to be sure that this is not the case. ICS can be withdrawn in COPD patients without history of exacerbations <https://bit.ly/2TorQZd>
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
